IntegraGen SA (ALINT) Stock Statistics & Valuation Metrics

IntegraGen SA has a market cap or net worth of €967.06K. The enterprise value is ―.

IntegraGen SA has 6,727,332 shares outstanding. The number of shares has decreased by -2.65% in one year.

IntegraGen SA’s return on equity (ROE) is -0.15 and return on invested capital (ROIC) is -14.56%.

The current PE Ratio of IntegraGen SA is ―. IntegraGen SA’s PEG ratio is -0.32.

In the last 12 months, IntegraGen SA had revenue of 8.70M and earned -256.00K in profits. Earnings per share was -0.04.

In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.

IntegraGen SA pays an annual dividend of ―, resulting in a dividend yield of ―

IntegraGen SA upcoming earnings date is Oct 16, 2025, TBA (Confirmed).

IntegraGen SA as a current ratio of 2.72, with Debt / Equity ratio of 36.64%

In the past 12 months, IntegraGen SA has paid -96.00K in taxes.

IntegraGen SA EV to EBITDA ratio is -8.61, with an EV/FCF ratio of 0.00.

IntegraGen SA has €1.90M in cash and marketable securities with €643.00K in debt, giving a net cash position of €1.26M billion.

Gross margin is 6.08%, with operating margin of -9.28%, and net profit margin of -2.94%.

The average price target for IntegraGen SA is ―, which is 11.43% higher than the current price. The consensus rating is ―